The global Glioblastoma Multiforme treatment market is on track for significant expansion, with a projected value of USD 5.68 billion by 2031. This translates to a compelling compound annual growth rate (CAGR) of 9.8% during the forecast period of 2024-2031, according to a recent market analysis. The market was valued at USD 2.69 billion in 2023. This press release explores the market...